Replies to post #100759 on Biotech Values

[zipjet]

and the copaxone headaches go away

I bet TEVA would love to do that.

But it would never pass anti-trust review without M356 being spun off.

ij

Note: DD pointed out my error on the Copaxone program error and this post corrects that.